Display options
Cite
Chen HB, Zhao CJ, Wang H, et al. [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011]. Zhonghua Nei Ke Za Zhi. 2013;52(3):203-12
Chen, H. B., Zhao, C. J., Wang, H., Cao, B., Xu, X. L., Chu, Y. Z., Hu, Z. D., Zhuo, C., Hu, B. J., Liu, W. E., Liao, K., Zhang, R., Zeng, J., Wang, Y., Luo, Y. P., Wang, Z. W., Liu, Y. M., Chen, X., Tian, B., Su, D. H., Zhou, C. M., Zou, M. X., Guo, P. H., Zhou, H. W., & Jin, Y. (2013). [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011]. Zhonghua nei ke za zhi, 52(3), 203-12.
Chen, Hong-bin, et al. "[An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011]." Zhonghua nei ke za zhi vol. 52,3 (2013): 203-12.
Chen HB, Zhao CJ, Wang H, Cao B, Xu XL, Chu YZ, Hu ZD, Zhuo C, Hu BJ, Liu WE, Liao K, Zhang R, Zeng J, Wang Y, Luo YP, Wang ZW, Liu YM, Chen X, Tian B, Su DH, Zhou CM, Zou MX, Guo PH, Zhou HW, Jin Y. [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011]. Zhonghua Nei Ke Za Zhi. 2013 Mar;52(3):203-12. Chinese. PMID: 23856111.
Copy Download .nbib Format: NLM
Share it on

Zhonghua Nei Ke Za Zhi. 2013 Mar;52(3):203-12.

[An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].

Zhonghua nei ke za zhi

[Article in Chinese]
Hong-bin Chen, Chun-jiang Zhao, Hui Wang, Bin Cao, Xiu-li Xu, Yun-zhuo Chu, Zhi-dong Hu, Chao Zhuo, Bi-jie Hu, Wen-en Liu, Kang Liao, Rong Zhang, Ji Zeng, Yong Wang, Yan-ping Luo, Zhan-wei Wang, Ying-mei Liu, Xiao Chen, Bin Tian, Dan-hong Su, Chun-mei Zhou, Ming-xiang Zou, Peng-hao Guo, Hong-wei Zhou, Yan Jin

Affiliations

  1. Department of Clinical Laboratory, Peking University People's Hospital, Beijing 100044, China.

PMID: 23856111

Abstract

OBJECTIVE: To investigate the pathogen profile of nosocomial infection in China, and to survey the susceptibility rates of these pathogens to the clinical common antibiotics.

METHODS: The non-repetitive nosocomial pathogens isolated from bloodstream infection (BSI), hospital acquired pneumonia (HAP) and intra-abdominal infection (IAI) and the case data were collected from 13 teaching hospitals in different areas of China and sent to a central laboratory for re-identification and susceptibility testing. The levels of minimal inhibitory concentration (MIC) of the common antibiotics were determined by agar dilution method. The data were analyzed by WHONET 5.6 software.

RESULTS: A total of 2103 clinical isolates were collected from January to December 2011, of which gram positive cocci and gram negative organisms accounted for 23.2% and 76.8% respectively. The top three pathogens of BSI were E. coli (31.0%, 243/784), K. pneumoniae (14.8%, 116/784) and S. aureus (10.6%, 83/784). The top three pathogens of HAP were A. baumannii (24.2%, 158/652), P. aeruginosa (23.0%, 150/652) and K. pneumoniae (16.4%, 107/652). The top three pathogens of IAI were E. coli (34.3%, 229/667), E. faecium (13.3%, 89/667) and K. pneumoniae (9.6%, 64/667). Methicillin-resistant S. aureus (MRSA) and coagulase negative Staphylococcus (MRCNS) accounted for 64.4% and 78.1% respectively. The susceptibility rates of Staphylococcus species to tigecycline, vancomycin, teicoplanin and linezolid were all 100%. The prevalence of MRSA in HAP was significantly higher than that in BSI or IAI. The susceptibility rates of Enterococcus species to tigecycline, teicoplanin and linezolid were all 100%. The prevalence of extended-spectrum β-lactamases (ESBL) was 64.3% in E. coli and 38.3% in K. pneumonia. Against Enterobacteriaceae, the most active agents were as following in order: tigecycline (92.3% - 100%) [except P.mirabilis], meropenem (87.5% - 100%), imipenem (87.5% - 100%) [except M. morganii], amikacin (87.5% - 100%), polymyxin B (75% - 100%) [except S. marcescens, P. mirabilis and M morganii], cefepime (67.8% - 100%), cefoperazone-sulbactam (66.6% - 100%), piperacillin-tazobactam (61.5% - 100%). Carbapenem-resistance Enterobacteriaceae strains emerged. The susceptibility rates of P. aeruginosa to imipenem and meropenem were 66.2% and 72.2%, respectively. The susceptibility rates of A. baumannii to imipenem and meropenem were 27.7% and 25.9%, respectively. The most active agents against A. baumannii were polymyxin B (100%), followed by tigecycline (79.8%) and minocycline (50.4%). The susceptibility rates of P.aeruginosa to antibiotics in BSI were higher than those in HAP and IAI. Susceptibility rates of S. maltophilia to trimethoprim-sulfamethoxazole, minocycline and levofloxacin were about 90% or above. Susceptibility rates of B. cepacia to trimethoprim-sulfamethoxazole, ceftazidime and meropenem were all 100%. Several P.aeruginosa and A. baumannii strains were resistant to all tested antibiotics except polymyxin B.

CONCLUSIONS: The pathogen profile is different in different types of infection. The prevalence of multi-drug resistant A. baumannii is high, which is still a key problem of nosocomial infection. Tigecycline remains relatively high activity against gram-positive cocci and gram-negative bacteria (except P. aeruginosa and P. mirabilis) in vitro.

MeSH terms

Publication Types